We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
(+9.5%)
Cap. Flow
+$272M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$208M |
| 2 |
Charles River Laboratories
CRL
|
+$150M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$91.1M |
| 4 |
Keurig Dr Pepper
KDP
|
+$83.8M |
| 5 |
Medtronic
MDT
|
+$83.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$170M |
| 2 |
Boston Scientific
BSX
|
+$145M |
| 3 |
Procter & Gamble
PG
|
+$139M |
| 4 |
EPAM Systems
EPAM
|
+$101M |
| 5 |
Fidelity National Information Services
FIS
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.06% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Financials | 10.11% |
| 4 | Technology | 9.6% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Fidelity National Information Services
FIS
$21.5B
| $93M | 0.6% |
631,972
-529,905
| -46% | -$76.6M |
|
27
Mastercard
MA
$477B
| $92.8M | 0.59% |
274,466
+49,375
| +22% | +$16.1M |
|
28
UBS Group
UBS
$170B
| $91.9M | 0.59% |
8,199,014
-877,423
| -10% | -$10.5M |
|
29
Apple
AAPL
$4.89T
| $88.1M | 0.56% |
761,037
-79,963
| -10% | -$8.73M |
|
|
30
Medtronic
MDT
$107B
| $86.1M | 0.55% |
+828,645
| New | +$83.2M |
|
31
Domino's
DPZ
$11B
| $82.1M | 0.53% |
193,019
+175,186
| +982% | +$69.8M |
|
32
Meta Platforms (Facebook)
META
$1.51T
| $82.1M | 0.53% |
313,381
+16,978
| +6% | +$4.38M |
|
33
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $81.1M | 0.52% |
513,000
-115,700
| -18% | -$19.2M |
|
34
Adobe
ADBE
$89.5B
| $81.1M | 0.52% |
165,310
+35,044
| +27% | +$16.3M |
|
35
JPMorgan Chase
JPM
$939B
| $79.4M | 0.51% |
825,034
+41,679
| +5% | +$4.09M |
|
|
36
Keurig Dr Pepper
KDP
$40.4B
| $78.9M | 0.51% |
+2,859,399
| New | +$83.8M |
|
37
Nike
NKE
$61.9B
| $78.6M | 0.5% |
626,154
+498,811
| +392% | +$53.6M |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $77.3M | 0.49% |
3,012,377
+1,694,447
| +129% | +$38.7M |
|
39
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $73.4M | 0.47% |
4,332,400
+2,711,400
| +167% | +$48.1M |
|
40
Willis Towers Watson
WTW
$27.9B
| $72.8M | 0.47% |
348,527
+115,906
| +50% | +$23.7M |
|
41
Deere & Co
DE
$170B
| $71.7M | 0.46% |
323,617
+301,376
| +1,355% | +$58.2M |
|
|
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $71.1M | 0.46% |
+428,399
| New | +$58.6M |
|
43
FedEx
FDX
$74.5B
| $69.6M | 0.45% |
+276,656
| New | +$55.3M |
|
44
CALL
iShares China Large-Cap ETF
FXI
$4.31B
| $69.6M | 0.45% |
1,465,500
+552,300
| +60% | +$23.7M |
|
45
Linde
LIN
$237B
| $69.3M | 0.44% |
292,681
+144,528
| +98% | +$35M |
|
46
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
| $68.2M | 0.44% |
927,876
+475,940
| +105% | +$33.7M |
|
|
47
PUT
iShares China Large-Cap ETF
FXI
$4.31B
| $67.8M | 0.43% |
1,428,000
+804,200
| +129% | +$34.6M |
|
48
CALL
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $67.2M | 0.43% |
+1,109,600
| New | +$62.7M |
|
49
Wells Fargo
WFC
$261B
| $65.2M | 0.42% |
2,773,597
-670,231
| -19% | -$16.5M |
|
50
Morgan Stanley
MS
$337B
| $62.5M | 0.4% |
1,292,627
+1,087,610
| +530% | +$54.8M |
|
Similar funds
Marshall Wace's Q3 2020 Portfolio in Review
As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
- Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
- Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
- Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
- Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
- Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
- Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.
Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.